Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas

被引:0
|
作者
Mendel Castle-Kirszbaum
Yi Yuen Wang
James King
Tony Goldschlager
机构
[1] Monash Health,Department of Neurosurgery
[2] St Vincent’s Health,Department of Neurosurgery
[3] Royal Melbourne Hospital,Department of Neurosurgery
[4] Monash University,Department of Surgery
来源
Neurosurgical Review | 2022年 / 45卷
关键词
Transsphenoidal; Pituitary; Adenoma; Vision; Endocrine; Outcome;
D O I
暂无
中图分类号
学科分类号
摘要
Surgery for pituitary adenoma is indicated for relief of mass effect and control of endocrinopathy. Setting benchmarks for visual and hormonal outcomes is important for monitoring performance of surgical centres, while understanding the preoperative factors that predict endocrine cure and visual improvement facilitates tailored counselling for patients prior to surgery. A prospective, consecutive cohort of surgically managed (endoscopic transsphenoidal) pituitary adenoma (n = 304) were analysed. Preoperative and postoperative endocrine and visual field assessments were performed and compared to demographic, imaging and pathological data. Larger adenomas tended to have preoperative endocrine deficiency (p < 0.001) and visual field defects (p < 0.001). The largest tumours did not experience normalisation of their endocrinopathy or visual fields with surgery. Of the adenomas with normal preoperative endocrine function, 92.0% (126/137) maintained this postoperatively; only 2 of the 11 patients with new hypopituitarism required long-term hormone replacement. Functional tumour cure was achieved in 65.2% (86/116) after surgery; 74.4% (32/43) of acromegalics and 70.0 (35/50) of Cushing’s disease patients achieved hormonal control. All patients with isolated hyperprolactinaemia from stalk effect normalised with surgery, while only 15.9% (7/44) with hypopituitarism recovered normal endocrine function. New hypopituitarism was predicted by younger age and functional adenoma, particularly Cushing’s disease. Resolution of endocrinopathy was less likely with reoperative cases and those with cavernous sinus invasion (Knosp grade > 2) or preoperative ophthalmoplegia. One-third of the cohort (102/304, 33.6%) had a preoperative field cut, most commonly an incomplete (51.0%) or complete (31.4%) bitemporal hemianopsia. Only two patients (2/304, 0.7%) had visual field worsening after surgery, while 71.6% (73/102) experienced partial or complete resolution of their field cut after surgery. Complete resolution of visual field defect was predicted by younger age and incomplete bitemporal hemianopsia. Surgery is a safe and effective therapy for pituitary adenomas. Nearly all patients experience improvement in visual fields, especially the young and those with incomplete bitemporal defects. Reoperative cases and those with cavernous sinus involvement (high Knosp grade/ophthalmoplegia) are less likely to have resolution of endocrinopathy. Visual worsening, new ophthalmoplegia or endocrinopathy were rare complications of surgery.
引用
收藏
页码:843 / 853
页数:10
相关论文
共 50 条
  • [1] Predictors of visual and endocrine outcomes after endoscopic transsphenoidal surgery for pituitary adenomas
    Castle-Kirszbaum, Mendel
    Wang, Yi Yuen
    King, James
    Goldschlager, Tony
    [J]. NEUROSURGICAL REVIEW, 2022, 45 (01) : 843 - 853
  • [2] PREDICTORS OF ENDOCRINE OUTCOME AFTER ENDOSCOPIC TRANSSPHENOIDAL SURGERY FOR NON-FUNCTIONING PITUITARY ADENOMAS
    Hwang, Jenie
    Yum, Diane
    Chicoine, Michael
    Dacey, Ralph
    Osbun, Joshua
    Rich, Keith
    Zipfel, Gregory
    Klatt-Cromwell, Cristine
    Mcjunkin, Jonathan
    Pipkorn, Patrik
    Schneider, John
    Silverstein, Julie
    Kim, Albert
    [J]. NEURO-ONCOLOGY, 2020, 22 : 141 - 141
  • [3] Endocrine outcome of endoscopic endonasal transsphenoidal surgery in functioning pituitary adenomas
    Choe, Jai-Ho
    Lee, Kun-Soo
    Jeun, Sin-Soo
    Cho, Jin-Hee
    Hong, Yong-Kil
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2008, 44 (03) : 151 - 155
  • [4] Visual outcomes after endoscopic pituitary adenomas surgery: our experience
    Fernandes, Carla
    Nunes, Lidia
    Lorga, Tiago
    Costa, Joao
    [J]. ACTA OPHTHALMOLOGICA, 2022, 100
  • [5] VISUAL OUTCOME AFTER TRANSSPHENOIDAL SURGERY FOR PITUITARY-ADENOMAS
    PETER, M
    DETRIBOLET, N
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 1995, 9 (02) : 151 - 157
  • [6] Endoscopic endonasal transsphenoidal surgery for pituitary adenomas
    Saeki, Naokatsu
    Murai, Hisayuki
    Hasegawa, Yuzo
    Horiguchi, Kentaro
    [J]. NEUROLOGICAL SURGERY, 2007, 35 (10): : 971 - 985
  • [7] Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas
    Pinar, Ercan
    Yuceer, Nurullah
    Imre, Abdulkadir
    Guvenc, Gonul
    Gundogan, Onur
    [J]. JOURNAL OF CRANIOFACIAL SURGERY, 2015, 26 (01) : 205 - 209
  • [8] Visual Outcomes after Endoscopic Endonasal Transsphenoidal Resection of Pituitary Adenomas: Our Institutional Experience
    van Essen, Max J.
    Muskens, Ivo S.
    Lamba, Nayan
    Belunek, Stephan F. J.
    van der Boog, Arthur T. J.
    Amelink, G. Johan
    Gosselaar, Peter H.
    van Doormaal, Tristan P. C.
    Stades, Aline M. E.
    Verhoeff, Joost J. C.
    van Genderen, Maria M.
    Eenhorst, Christine A. E.
    Broekman, Marike L. D.
    [J]. JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2021, 82 : E79 - E87
  • [9] Olfactory Outcomes After Endoscopic Transsphenoidal Pituitary Surgery
    Rotenberg, Brian W.
    Saunders, Samantha
    Duggal, Neil
    [J]. LARYNGOSCOPE, 2011, 121 (08): : 1611 - 1613
  • [10] Cons: endoscopic endonasal transsphenoidal pituitary surgery is not superior to microscopic transsphenoidal surgery for pituitary adenomas
    Pietro Mortini
    [J]. Endocrine, 2014, 47 : 415 - 420